Qlife Holding
2.48 SEK
-16.78 %
Less than 1K followers
QLIFE
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-16.78 %
+48.50 %
-17.33 %
-13.89 %
+23.88 %
+25.74 %
-99.60 %
-99.95 %
-99.90 %
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.
Read moreMarket cap
38.89M SEK
Turnover
1.94M SEK
Revenue
90K
EBIT %
-61,500 %
P/E
-
Dividend yield-%
-
Latest research
Latest analysis report
Released: 2023-12-07
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
11/2
2026
Annual report '25
13/5
2026
Interim report Q1'26
27/5
2026
General meeting '26
All
Research
Webcasts
Press releases
ShowingAll content types
Qlife Holding AB: Qlife and Hipro sign exclusive commercial agreement covering Qlife's sale of Hipro products in EU and US markets
Qlife Holding AB: The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools